Aligos Therapeuticsinc Stock Price Prediction
| ALGS Stock | USD 0.83 0 0.12% |
Oversold Vs Overbought
61
Oversold | Overbought |
Aligos TherapeuticsInc stock price prediction is an act of determining the future value of Aligos TherapeuticsInc shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Aligos TherapeuticsInc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aligos TherapeuticsInc and does not consider all of the tangible or intangible factors available from Aligos TherapeuticsInc's fundamental data. We analyze noise-free headlines and recent hype associated with Aligos TherapeuticsInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Aligos TherapeuticsInc's stock price prediction:EPS Estimate Next Quarter (0.27) | EPS Estimate Current Year (0.83) | EPS Estimate Next Year (0.82) | Wall Street Target Price 4 | Quarterly Revenue Growth (0.24) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Aligos TherapeuticsInc based on different types of headlines from major news networks to social media. The Aligos stock price prediction module provides an analysis of price elasticity to changes in media outlook on Aligos TherapeuticsInc over a specific investment horizon. Using Aligos TherapeuticsInc hype-based prediction, you can estimate the value of Aligos TherapeuticsInc from the perspective of Aligos TherapeuticsInc response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Aligos TherapeuticsInc using Aligos TherapeuticsInc's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Aligos using crowd psychology based on the activity and movement of Aligos TherapeuticsInc's stock price.
Aligos TherapeuticsInc Implied Volatility | 0.0 |
Aligos TherapeuticsInc's implied volatility exposes the market's sentiment of Aligos TherapeuticsInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Aligos TherapeuticsInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Aligos TherapeuticsInc stock will not fluctuate a lot when Aligos TherapeuticsInc's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Aligos TherapeuticsInc. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Aligos TherapeuticsInc to buy its stock at a price that has no basis in reality. In that case, they are not buying Aligos because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aligos TherapeuticsInc after-hype prediction price | USD 0.76 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aligos |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aligos TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aligos TherapeuticsInc After-Hype Price Prediction Density Analysis
As far as predicting the price of Aligos TherapeuticsInc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aligos TherapeuticsInc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aligos TherapeuticsInc, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aligos TherapeuticsInc Estimiated After-Hype Price Volatility
In the context of predicting Aligos TherapeuticsInc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aligos TherapeuticsInc's historical news coverage. Aligos TherapeuticsInc's after-hype downside and upside margins for the prediction period are 0.04 and 6.55, respectively. We have considered Aligos TherapeuticsInc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aligos TherapeuticsInc is dangerous at this time. Analysis and calculation of next after-hype price of Aligos TherapeuticsInc is based on 3 months time horizon.
Aligos TherapeuticsInc Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aligos TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aligos TherapeuticsInc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aligos TherapeuticsInc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.45 | 5.79 | 0.07 | 0.08 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.83 | 0.76 | 8.32 |
|
Aligos TherapeuticsInc Hype Timeline
Aligos TherapeuticsInc is presently traded for 0.83. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.08. Aligos is forecasted to decline in value after the next headline, with the price expected to drop to 0.76. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -8.32%, whereas the daily expected return is presently at 0.45%. The volatility of related hype on Aligos TherapeuticsInc is about 3239.16%, with the expected price after the next announcement by competition of 0.75. About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aligos TherapeuticsInc recorded a loss per share of 1.36. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Aligos TherapeuticsInc Basic Forecasting Models to cross-verify your projections.Aligos TherapeuticsInc Related Hype Analysis
Having access to credible news sources related to Aligos TherapeuticsInc's direct competition is more important than ever and may enhance your ability to predict Aligos TherapeuticsInc's future price movements. Getting to know how Aligos TherapeuticsInc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aligos TherapeuticsInc may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CTMX | CytomX Therapeutics | (0.10) | 10 per month | 3.82 | 0.02 | 8.16 | (5.80) | 50.71 | |
| SPRO | Spero Therapeutics | 0.08 | 9 per month | 3.29 | 0 | 4.82 | (5.59) | 16.20 | |
| NLTX | Neoleukin Therapeutics | (0.12) | 2 per month | 0.00 | (0.04) | 6.67 | (5.67) | 15.97 | |
| TIL | Instil Bio | (0.24) | 7 per month | 1.99 | 0.04 | 4.48 | (3.60) | 18.48 | |
| NXTC | NextCure | 0.15 | 4 per month | 4.85 | 0.09 | 8.13 | (7.93) | 32.17 | |
| ASMB | Assembly Biosciences | (1.88) | 7 per month | 3.30 | 0.10 | 6.20 | (4.63) | 19.82 | |
| ACHL | Achilles Therapeutics PLC | (0.02) | 10 per month | 6.04 | 0 | 9.56 | (9.02) | 38.89 | |
| NUVB | Nuvation Bio | 0.70 | 9 per month | 3.98 | 0.13 | 16.67 | (6.50) | 46.16 |
Aligos TherapeuticsInc Additional Predictive Modules
Most predictive techniques to examine Aligos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aligos using various technical indicators. When you analyze Aligos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aligos TherapeuticsInc Predictive Indicators
The successful prediction of Aligos TherapeuticsInc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aligos TherapeuticsInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aligos TherapeuticsInc based on analysis of Aligos TherapeuticsInc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aligos TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aligos TherapeuticsInc's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 5.25 | 4.03 | 5.9 | 8.15 | Net Debt To EBITDA | 1.34 | 0.7 | 1.48 | 1.01 |
Story Coverage note for Aligos TherapeuticsInc
The number of cover stories for Aligos TherapeuticsInc depends on current market conditions and Aligos TherapeuticsInc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aligos TherapeuticsInc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aligos TherapeuticsInc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Aligos TherapeuticsInc Short Properties
Aligos TherapeuticsInc's future price predictability will typically decrease when Aligos TherapeuticsInc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aligos TherapeuticsInc often depends not only on the future outlook of the potential Aligos TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aligos TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 64.3 M | |
| Cash And Short Term Investments | 135.8 M |
Check out Aligos TherapeuticsInc Basic Forecasting Models to cross-verify your projections. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.